Clinical Trials Browser

Unknown × PEGPH20 × Clear all

NCT03634332 2019-05-07

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms